查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611308

去肾神经技术市场：按技术、按原因 - 2025-2030 年全球预测

Renal Denervation Technologies Market by Technology (Microinfusion, Radiofrequency, Ultrasound), Cause (Diabetes, Heart Failure, Hypertension) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肾去神经技术市值为3.1144亿美元，预计到2024年将达到3.7415亿美元，复合年增长率为18.02%，预计到2030年将达到9.9333亿美元。

去肾神经技术是一种专注于破坏肾动脉神经活动以治疗顽固性高血压和相关心血管疾病的医疗程序。这种微创手术使用射频消融术、超音波和其他治疗方法来减少交感神经活动，为对传统治疗方法没有反应的患者提供了另一种选择。高血压及其相关风险的盛行率不断增加，从而推动了对创新治疗解决方案的需求，因此需要去肾神经术。肾去神经术的应用范围已从高血压扩展到慢性肾臟病、心臟衰竭和METABOLIC INC.综合征，扩大了医院和专科诊所的最终用途范围。

主要市场统计
基准年[2023] 31144万美元
预计年份 [2024] 37415万美元
预测年份 [2030] 99333万美元
复合年增长率（%） 18.02%

去肾神经技术的市场开拓受到世界人口老化、高血压发病率上升、设备技术进步以及已开发地区支持性报销政策等因素的影响。改进的导管和非侵入性技术等创新带来了巨大的商机。然而，有限的长期疗效资料、严格的法规环境、高昂的设备成本以及新兴市场的认知度低给市场拓展带来了挑战。为了抓住机会，公司应注重策略伙伴关係关係，开拓全面的临床试验资料，并在开拓的市场中拓展地域。

创新研究领域包括改进消融技术、寻找个人化治疗的遗传标记以及开髮用于患者管理的整合监测设备。去肾神经市场的本质是动态的，其特征是不断的技术进步和日益激烈的竞争。公司必须优先考虑设备设计、功效和安全性方面的创新，以提高采用率。此外，针对医疗保健专业人员和患者的教育倡议对于提高对肾去神经术益处的认识至关重要。随着市场的发展，透过促进该技术在各种医疗应用中的接受度，同时解决成本和可及性等痛点，将具有巨大的成长潜力。

市场动态：快速发展的去肾神经技术市场的关键市场洞察

供需的动态交互作用正在改变肾去神经技术市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 人口老化加剧和高血压盛行率上升
    • 微创手术日益偏好青睐
    • 扩大医疗支出和基础设施发展
  • 市场限制因素
    • 去肾神经手术缺乏报销
  • 市场机会
    • 正在进行的肾去神经技术研究
    • 新产品上市并获得多个监管机构的核准
  • 市场挑战
    • 缺乏与 RDN 手术相关的长期临床资料和风险

波特五力：驾驭去肾臟神经科技市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解去肾神经技术市场的外部影响

外部宏观环境因素在塑造去肾神经技术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解去肾神经技术市场的竞争格局

对肾去神经技术市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵去肾神经技术市场供应商的绩效评估

FPNV 定位矩阵是评估肾去神经技术市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划去肾神经技术市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对肾臟去神经技术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化加剧和高血压盛行率上升
      • 人们对微创手术的兴趣日益浓厚
      • 扩大医疗保健支出并改善基础设施
    • 抑制因素
      • 肾去神经手术缺乏报销
    • 机会
      • 肾去神经技术的持续研究与调查
      • 新产品上市并获得多个监管机构核准
    • 任务
      • 缺乏与 RDN 手术相关的长期临床资料和风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章去肾臟神经技术市场：依技术分类

  • 微量输液
  • 无线电频率
  • 超音波

第七章去肾臟神经技术市场的原因

  • 糖尿病
  • 心臟衰竭
  • 高血压

第八章 美洲去肾神经技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区去肾臟神经技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲去肾臟神经技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Ablative Solutions, Inc.
  • Boston Scientific Corporation
  • Cordis Corporation
  • Medtronic PLC
  • Mentice
  • Mercator Medsystems, Inc.
  • Otsuka Medical Devices Co., Ltd.
  • Recor Medical, Inc.
  • SoniVie Ltd.
  • Symple Surgical, Inc.
  • Terumo Corporation
Product Code: MRR-02026C4CB064

The Renal Denervation Technologies Market was valued at USD 311.44 million in 2023, expected to reach USD 374.15 million in 2024, and is projected to grow at a CAGR of 18.02%, to USD 993.33 million by 2030.

Renal denervation technologies are medical procedures focused on disrupting nerve activity in the renal arteries to treat resistant hypertension and related cardiovascular conditions. This minimally invasive technique involves using radiofrequency ablation, ultrasound, or other modalities to reduce sympathetic nerve activity, offering an alternative for patients unresponsive to conventional therapies. The necessity of renal denervation arises from the increasing prevalence of hypertension and associated risks, driving demand for innovative treatment solutions. Its applications are extending beyond hypertension to include chronic kidney disease, heart failure, and metabolic syndrome, enhancing the procedure's end-use scope in hospitals and specialty clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 311.44 million
Estimated Year [2024] USD 374.15 million
Forecast Year [2030] USD 993.33 million
CAGR (%) 18.02%

Market growth for renal denervation technologies is influenced by factors like an aging global population, rising rates of hypertension, advances in device technology, and supportive reimbursement policies in developed regions. Innovations, such as improved catheters and non-invasive techniques, present significant opportunities. However, market expansion is challenged by limited long-term efficacy data, stringent regulatory environments, high device costs, and lack of awareness in emerging markets. To seize opportunities, companies should focus on strategic partnerships, developing comprehensive clinical trial data, and expanding geographical footprint in underpenetrated markets.

Innovative research areas include improving ablation techniques, exploring genetic markers for personalized treatment, and developing integrated monitoring devices for patient management. The nature of the renal denervation market is dynamic, characterized by ongoing technological advancements and increasing competition. Companies should prioritize innovation in device design, efficacy, and safety to enhance adoption rates. Furthermore, educational initiatives targeting healthcare professionals and patients are crucial to raising awareness about the benefits of renal denervation. As the market evolves, there is significant potential for growth by addressing pain points such as cost and accessibility while promoting acceptance of the technology across diverse medical applications.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Renal Denervation Technologies Market

The Renal Denervation Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing aging population and rising prevalence of hypertension
    • Increasing preference for minimally invasive procedures
    • Expanding healthcare spending and infrastructure improvement
  • Market Restraints
    • Lack of reimbursements for renal denervation procedures
  • Market Opportunities
    • Ongoing studies and research about renal denervation technologies
    • New product launches and approvals by several regulatory agencies
  • Market Challenges
    • Lack of long-term clinical data and risks associated with RDN procedure

Porter's Five Forces: A Strategic Tool for Navigating the Renal Denervation Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Renal Denervation Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Renal Denervation Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Renal Denervation Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Renal Denervation Technologies Market

A detailed market share analysis in the Renal Denervation Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Renal Denervation Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Renal Denervation Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Renal Denervation Technologies Market

A strategic analysis of the Renal Denervation Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Renal Denervation Technologies Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ablative Solutions, Inc., Boston Scientific Corporation, Cordis Corporation, Medtronic PLC, Mentice, Mercator Medsystems, Inc., Otsuka Medical Devices Co., Ltd., Recor Medical, Inc., SoniVie Ltd., Symple Surgical, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Renal Denervation Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Microinfusion, Radiofrequency, and Ultrasound.
  • Based on Cause, market is studied across Diabetes, Heart Failure, and Hypertension.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging population and rising prevalence of hypertension
      • 5.1.1.2. Increasing preference for minimally invasive procedures
      • 5.1.1.3. Expanding healthcare spending and infrastructure improvement
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursements for renal denervation procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing studies and research about renal denervation technologies
      • 5.1.3.2. New product launches and approvals by several regulatory agencies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of long-term clinical data and risks associated with RDN procedure
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Renal Denervation Technologies Market, by Technology

  • 6.1. Introduction
  • 6.2. Microinfusion
  • 6.3. Radiofrequency
  • 6.4. Ultrasound

7. Renal Denervation Technologies Market, by Cause

  • 7.1. Introduction
  • 7.2. Diabetes
  • 7.3. Heart Failure
  • 7.4. Hypertension

8. Americas Renal Denervation Technologies Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Renal Denervation Technologies Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Renal Denervation Technologies Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Ablative Solutions, Inc.
  • 3. Boston Scientific Corporation
  • 4. Cordis Corporation
  • 5. Medtronic PLC
  • 6. Mentice
  • 7. Mercator Medsystems, Inc.
  • 8. Otsuka Medical Devices Co., Ltd.
  • 9. Recor Medical, Inc.
  • 10. SoniVie Ltd.
  • 11. Symple Surgical, Inc.
  • 12. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. RENAL DENERVATION TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. RENAL DENERVATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. RENAL DENERVATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RENAL DENERVATION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RENAL DENERVATION TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY MICROINFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 101. RENAL DENERVATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. RENAL DENERVATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023